Posts in Commercialization

Editorial business illustration showing a giant wasp approaching a Takeda executive in a boardroom as dominoes labeled patent cliff, revenue erosion, cost savings, and workforce reduction begin to fall.
by Stefan Sandström
May 25, 2026

Takeda is Living the Japanese Proverb: “Wasp stings a crying eye”

The High Stakes of Innovation: Balancing Takeda’s $1.26B ‘Launch Machine’ and a $2.5B Antitrust Hit as […]
0
read more
Foreign pharmaceutical executive and Japanese CRO team collaborating on clinical trials.
by Stefan Sandström
January 8, 2024

Partnering with Japanese CROs: A Strategic Imperative for Pharma Expansion in Japan CHECKLIST

Expanding your pharmaceutical operations into Japan is a strategic move with an immense growth potential. However, […]
0
read more